EFB is committed to fulfilling unmet medical needs
EFB is committed to fulfilling unmet medical needs by developing orphan drugs to treat the world’s most lethal diseases.
Glioblastoma (GBM) and
Pancreatic cancer (PC)
Everfront Biotech Inc. Receives "Investor's Choice Award" at the 2023 NBRP Demo Day Investment Matchmaking Competition
PRODUCT HIGHLIGHTS of Cerebraca® Wafer
A Biodegradable Implant Targeting GBM with One-month Sustained Drug Release